Sorry - There were no pages found that contain that search phrase.
 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Boston, MA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme |
|
Boston, MA USA |
|
04/27/2008 |
|
|
|
Details |
|
Effect of NovoTTF-100A in Recurrent GBM |
|
Boston, MA USA |
|
04/16/2008 |
|
|
|
|
|
Details |
|
Effect of NovoTTF-100A in Recurrent GBM |
|
Burlington, MA USA |
|
04/16/2008 |
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Boston, MA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma |
|
Boston, MA USA |
|
04/15/2008 |
|
|
|
Details |
|
Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas |
|
Boston, MA USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Boston, MA USA |
|
03/01/2008 |
|
|
|
Details |
|
Gliogene: Brain Tumor Linkage Study |
|
Boston, MA USA |
|
01/17/2008 |
|
|
|
|
|
Details |
|
NABTC 04-01: Lapatinib in Treating Patients Who Are Undergoing Surgery for Recurrent Progressive Glioblastoma Multiforme or Gliosarcoma |
|
Boston, MA |
|
10/03/2007 |
|
|
|
Details |
|
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
Boston, MA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial of Erlotinib (OSI-774) and Sorafenib (BAY 43-9006) for Patients With Progression or Recurrent Glioblastoma Multiforme |
|
Boston, MA USA |
|
08/26/2007 |
|
|
|
Details |
|
Phase I/II Study of Fractionated CyberKnife Stereotactic Radiosurgery for High Grade Gliomas in Elderly Patients With Poor Performance Status |
|
Boston, MA USA |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase I, Open Label Study of AT-101 (Gossypol) Plus Radiotherapy and Temozolomide and of AT-101 Plus Adjuvant Temozolomide for Patients With Newly-Diagnosed Glioblastoma Multiforme |
|
Boston, MA USA |
|
08/19/2007 |
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
Boston, MA USA |
|
08/19/2007 |
|
|
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
Boston, MA USA |
|
08/19/2007 |
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
Boston, MA |
|
08/19/2007 |
|
|
|
|
|
Details |
|
A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme |
|
Boston, MA |
|
08/19/2007 |
|
|
|
Details |
|
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
|
Cambridge, MA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
|
Cambridge, MA USA |
|
08/18/2007 |
|
|
|
Details |
|
Brain Mapping for Brain Tumors |
|
Boston, MA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma |
|
Boston, MA |
|
08/04/2007 |
|
|
|
Details |
|
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
|
Cambridge, MA USA |
|
06/04/2007 |
|
|
|
|
|
Details |
|
Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma |
|
Boston, MA USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
|
Boston, MA USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma |
|
Boston, MA |
|
05/01/2007 |
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Boston, MA USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
|
|
Boston, MA USA |
|
05/01/2007 |
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Boston, MA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Trial of Talampanel in Conjunction With Radiation Therapy With Recurrent and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Boston, MA USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Boston, MA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma |
|
Boston, MA USA |
|
04/28/2007 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Springfield, MA USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Boston, MA USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Boston, MA USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase II Study of Rituximab, Temozolomide, and Methylprednisolone in Patients With Recurrent Primary CNS Non-Hodgkin`s Lymphoma |
|
Boston, MA USA |
|
05/27/2006 |
|
|
|
Details |
|
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors |
|
Boston, MA USA |
|
05/27/2006 |
|
|
|
|
|
Details |
|
PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
|
|
Boston, MA |
|
05/04/2006 |
|
|
|
Details |
|
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas |
|
Boston, MA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Springfield, MA USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Boston, MA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Boston, MA USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Worcester, MA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma
|
|
Boston, MA USA |
|
11/27/2005 |
|
|
|
Details |
|
Laser ablation of deep cerebral tumors in the intraoperative magnetic resonance unit. |
|
Boston, MA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas |
|
Boston, MA |
|
11/27/2005 |
|
|
|
Details |
|
Tipifarnib and Radiation Therapy in Treating Young Patients with Brainstem Glioma |
|
Boston, MA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Feasibility Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Lesions |
|
Boston, MA USA |
|
11/27/2005 |
|
|
|
Details |
|
Neurosurgical Use of Interstitial Laser Therapy (ILT) |
|
Boston, MA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Intraoperative navigation in neurosurgical patients |
|
Boston, MA USA |
|
11/26/2005 |
|
|
|
Details |
|
MGH 99-114. A phase II study of systemic topotecan in patients with CNS metastatic carcinoma |
|
Boston, MA USA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Phase II Study of Multi-Agent Intrathecal and Systemic Chemotherapy With Radiotherapy in Children With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors |
|
Boston, MA USA |
|
11/21/2005 |
|
|
|
Details |
|
Intraoperative MRI for brain tumors |
|
Boston, MA USA |
|
11/20/2005 |
|
|
|
|
|
Details |
|
Phase II Study of Prolonged Daily temozolomide for Low-Grade Glioma |
|
Boston, MA USA |
|
11/20/2005 |
|
|
|
Details |
|
Phase II Study of Prolonged Daily temozolomide for Low-Grade Glioma |
|
Boston, MA |
|
11/20/2005 |
|
|
|
|
|
Details |
|
FR901228 in Treating Patients With Recurrent High-Grade Gliomas |
|
Boston, MA |
|
11/13/2005 |
|
|
|
Details |
|
A Multicenter Phase II Study of TP-38 in Those Patients With Glioblastoma Multiforme Who Have Recurred or Progressed After Previous Resection and Radiation Therapy and Are Scheduled for Gross Total Resection
|
|
Boston, MA USA |
|
11/13/2005 |
|
|
|
|
|
Details |
|
TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma(or Glioblastoma multiforme) |
|
Boston, MA USA |
|
11/11/2005 |
|
|
|
Details |
|
FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia |
|
Boston, MA USA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors |
|
Boston, MA USA |
|
11/11/2005 |
|
|
|
Details |
|
Thalidomide and Temozolomide in Treating Young Patients With Relapsed or Progressive Brain Tumors or Recurrent Neuroblastoma
|
|
Boston, MA USA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors |
|
Boston, MA USA |
|
11/11/2005 |
|
|
|
Details |
|
Study of Lenalidomide and XRT in Patients with Newly Diagnosed Glioblastoma Multiforme |
|
Boston, MA USA |
|
11/09/2005 |
|
|
|
|
|
Details |
|
Study of Lenalidomide and XRT in Patients with Newly Diagnosed Glioblastoma Multiforme |
|
Boston, MA USA |
|
11/09/2005 |
|
|
|
Details |
|
Study of Lenalidomide and XRT in Patients with Newly Diagnosed Glioblastoma Multiforme |
|
Boston, MA |
|
11/09/2005 |
|
|
|
|
|
Details |
|
Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme |
|
Boston, MA |
|
11/06/2005 |
|
|
|
Details |
|
Phase I Study of Tipifarnib and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
Boston, MA |
|
11/06/2005 |
|
|
|
|
|
